Indeterminate cell histiocytosis in a patient with systemic lupus erythematosus and antiphospholipid antibody syndrome: an unusual association

被引:4
作者
Akdogan, N. [1 ]
Demircan, C. [1 ]
Bolek, E. Cagri [2 ]
Gokoz, O. [3 ]
Karaduman, A. [1 ]
机构
[1] Hacettepe Univ, Dept Dermatol & Venereol, Sch Med, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Div Rheumatol, Sch Med, Dept Internal Med, Ankara, Turkey
[3] Hacettepe Univ, Dept Pathol, Sch Med, Ankara, Turkey
关键词
Systemic lupus erythematosus; histiocytosis; indeterminate cell histocytosis; antiphospholipid syndrome; DISEASE;
D O I
10.1177/0961203319890675
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Indeterminate cell histiocytosis (ICH) is an extremely rare clonal proliferative disorder of dendritic cells which presents with skin lesions in the majority of cases. Although extra-cutaneous manifestations are very rare, ICH may involve the mucosa, cornea, and conjunctiva as well as the visceral organs. Since the clinical appearance of cutaneous lesions of ICH is not distinctive, it is diagnosed with histopathological and immunohistochemical findings after clinical suspicion. Herein, we report a 27-year-old man with a two-year history of asymptomatic reddish papules and papulonecrotic lesions on his face, arms and buttocks. He was previously diagnosed with systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome (APS), and he had been treated with hydroxychloroquine and low-dose aspirin. Diffuse dermal infiltration of a mixture of histiocytes and lymphocytes accompanied with multinuclear giant cells, the positive CD68 and Factor XIIIa and negative Langerin immunoreactions, along with the positive staining with CD1a and S100, led us to the diagnosis of ICH. To the best of our knowledge, this is the first case of ICH associated with SLE and APS.
引用
收藏
页码:74 / 78
页数:5
相关论文
共 50 条
  • [21] MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus
    Goldstein, R
    Moulds, JM
    Smith, CD
    Sengar, DPS
    [J]. JOURNAL OF RHEUMATOLOGY, 1996, 23 (07) : 1173 - 1179
  • [22] COMMUNICATING HYDROCEPHALUS IN SYSTEMIC LUPUS-ERYTHEMATOSUS WITH ANTIPHOSPHOLIPID ANTIBODY SYNDROME
    MORTIFEE, PRS
    BEBB, RA
    STEIN, H
    [J]. JOURNAL OF RHEUMATOLOGY, 1992, 19 (08) : 1299 - 1302
  • [23] Soluble cell molecules of adhesion in antiphospholipid syndrome associated with systemic lupus erythematosus, and primary antiphospholipid syndrome
    Aleksandrova, EN
    Novikov, AA
    Reshetnyak, TM
    Klyukvina, NG
    Reshetnyak, DV
    Samsonov, MY
    Nasonov, EL
    [J]. TERAPEVTICHESKII ARKHIV, 2002, 74 (05) : 23 - 27
  • [24] Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome
    Gordon, C
    Kilby, MD
    [J]. LUPUS, 1998, 7 (07) : 429 - 433
  • [25] Heart involvement in systemic lupus erythematosus and antiphospholipid syndrome
    Costedoat-Chalumeau, N.
    Le Guern, V
    Morel, N.
    [J]. REVUE DE MEDECINE INTERNE, 2021, 42 (10): : A220 - A222
  • [26] Management of Antiphospholipid Syndrome in Patients with Systemic Lupus Erythematosus
    Mary-Clair Yelovich
    Kimberly J. Legault
    [J]. Current Treatment Options in Rheumatology, 2019, 5 : 190 - 200
  • [27] Management of Antiphospholipid Syndrome in Patients with Systemic Lupus Erythematosus
    Yelovich, Mary-Clair
    Legault, Kimberly J.
    [J]. CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2019, 5 (03) : 190 - 200
  • [28] Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome
    Andreoli, Laura
    Fredi, Micaela
    Nalli, Cecilia
    Reggia, Rossella
    Lojacono, Andrea
    Motta, Mario
    Tincani, Angela
    [J]. JOURNAL OF AUTOIMMUNITY, 2012, 38 (2-3) : J197 - J208
  • [29] Primary antiphospholipid syndrome evolving into systemic lupus erythematosus
    Derksen, RHWM
    GmeligMeijling, FHJ
    deGroot, PG
    [J]. LUPUS, 1996, 5 (01) : 77 - 80
  • [30] Heart involvement in systemic lupus erythematosus and antiphospholipid syndrome
    Morel, N.
    Le Guern, V.
    Mouthon, L.
    Piette, J. -c.
    Costedoat-Chalumeau, N.
    [J]. REVUE DE MEDECINE INTERNE, 2022, 43 (11): : 645 - 648